Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kruithof

Showing results (21-30 of 493) with videos related to

Pageof 50
Sort By:
Work (Reading, Mass.)|November 19, 2025
In-chair movements: Categorizations and patterns over time based on a literature reviewAernout Kruithof, Yu Wolf Song, Peter Vink
Cancer Letters|November 18, 2022
Exploring prostate cancer in the post-genomic eraChee Wai Chua, Marianna Kruithof-de Julio
Thrombosis and Haemostasis|March 30, 2000
Cellular degradation of free and inhibitor-bound tissue-type plasminogen activator--requirement for a co-receptor?C Camani, O Gavin, E K Kruithof
Thrombosis and Haemostasis|September 8, 2004
A comparative study of amyloid-beta (1-42) as a cofactor for plasminogen activation by vampire bat plasminogen activator and recombinant human tissue-type plasminogen activatorEgbert K O Kruithof, Wolf-Dieter Schleuning
The Journal of Biological Chemistry|February 25, 1994
The role of plasminogen activator inhibitor type 1 in the clearance of tissue-type plasminogen activator by rat hepatoma cellsC Camani, F Bachmann, E K Kruithof
Experimental Cell Research|December 7, 2005
Evidence for serpinB2-independent protection from TNF-alpha-induced apoptosisRichard J Fish, Egbert K O Kruithof
BMC Molecular Biology|August 5, 2004
Short-term cytotoxic effects and long-term instability of RNAi delivered using lentiviral vectorsRichard J Fish, Egbert K O Kruithof
Blood|November 1, 1987
Plasminogen activator inhibitor 1: development of a radioimmunoassay and observations on its plasma concentration during venous occlusion and after platelet aggregationE K Kruithof, G Nicolosa, F Bachmann
Haemostasis|January 1, 1990
Antigen levels of plasminogen activator inhibitor type 1 in citrated plasma: determination of the contribution of plateletsV Grimaudo, F Bachmann, E K Kruithof
Cardiovascular Research|February 2, 2011
Epigenetic control of tissue-type plasminogen activator synthesis in human endothelial cellsSylvie Dunoyer-Geindre, Egbert K O Kruithof
Pageof 50

Showing results (21-30 of 493) with videos related to

Sort By:
Pageof 50
Work (Reading, Mass.)|November 19, 2025
In-chair movements: Categorizations and patterns over time based on a literature reviewAernout Kruithof, Yu Wolf Song, Peter Vink
Cancer Letters|November 18, 2022
Exploring prostate cancer in the post-genomic eraChee Wai Chua, Marianna Kruithof-de Julio
Thrombosis and Haemostasis|March 30, 2000
Cellular degradation of free and inhibitor-bound tissue-type plasminogen activator--requirement for a co-receptor?C Camani, O Gavin, E K Kruithof
Thrombosis and Haemostasis|September 8, 2004
A comparative study of amyloid-beta (1-42) as a cofactor for plasminogen activation by vampire bat plasminogen activator and recombinant human tissue-type plasminogen activatorEgbert K O Kruithof, Wolf-Dieter Schleuning
The Journal of Biological Chemistry|February 25, 1994
The role of plasminogen activator inhibitor type 1 in the clearance of tissue-type plasminogen activator by rat hepatoma cellsC Camani, F Bachmann, E K Kruithof
Experimental Cell Research|December 7, 2005
Evidence for serpinB2-independent protection from TNF-alpha-induced apoptosisRichard J Fish, Egbert K O Kruithof
BMC Molecular Biology|August 5, 2004
Short-term cytotoxic effects and long-term instability of RNAi delivered using lentiviral vectorsRichard J Fish, Egbert K O Kruithof
Blood|November 1, 1987
Plasminogen activator inhibitor 1: development of a radioimmunoassay and observations on its plasma concentration during venous occlusion and after platelet aggregationE K Kruithof, G Nicolosa, F Bachmann
Haemostasis|January 1, 1990
Antigen levels of plasminogen activator inhibitor type 1 in citrated plasma: determination of the contribution of plateletsV Grimaudo, F Bachmann, E K Kruithof
Cardiovascular Research|February 2, 2011
Epigenetic control of tissue-type plasminogen activator synthesis in human endothelial cellsSylvie Dunoyer-Geindre, Egbert K O Kruithof
Pageof 50